Aganepag isopropyl Completed Phase 2 Trials for Ocular Hypertension, Primary Open-angle Glaucoma (POAG) / Ocular Hypertension Treatment

Indications	Status	Purpose	Phase
DBCOND0088544 (Ocular Hypertension, Primary Open-angle Glaucoma (POAG)) DBCOND0074237 (Ocular Hypertension)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01110499	Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension	Aganepag isopropyl (DB16085) Bimatoprost (DB00905)